What sector does Revive Therapeutics Ltd (31R) operate in?
Revive Therapeutics Ltd belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.
What is Revive Therapeutics Ltd (31R) current stock price?
As of the latest data, Revive Therapeutics Ltd stock price is €0.02, with a previous close of €0.01. Revive Therapeutics Ltd gained €0.01 in the last trading session, representing a 200% increase.
What is Revive Therapeutics Ltd (31R) current market capitalization?
Revive Therapeutics Ltd market cap is approximately 6.28 million.
Does Revive Therapeutics Ltd (31R) pay dividends?
No. Revive Therapeutics Ltd does not pay a dividend.
When is Revive Therapeutics Ltd (31R) next earnings report?
Revive Therapeutics Ltd is expected to release its next earnings report on September 30, 2025.
What is Revive Therapeutics Ltd (31R) beta (volatility) score?
Revive Therapeutics Ltd has a beta of 1.026, meaning its volatility is roughly in line with the market.